18 and older, female only, with Opioid Use. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Morphine Milligram Equivalents Used During Inpatient StayPrimary· from immediately postoperative through discharge or 4 weeks, whichever comes first
Total morphine milligram equivalents calculated for each patient during their stay.
Group
Value
95% CI
Control Arm
10.8
± 5.6
Treatment Arm
8.8
± 7.1
Passage of Voiding TrialSecondary· from immediately postoperative through discharge or 4 weeks, whichever comes first
percentage of patients who pass voiding trial on POD#1
Group
Value
95% CI
Control Arm
4
Treatment Arm
4
Anti-emetic UseSecondary· postoperative day 1 through day of discharge from hospital; all patients were dischard on post-op day 1
Did the patient require anti-emetics in the post-operative period
Group
Value
95% CI
Control Arm
5
Treatment Arm
5
Patient Pain ScoreSecondary· postoperative day 7
Evaluated via the "Brief Pain Inventory (Short Form)"; rate pain on scale 0-10, 10 being worst
Group
Value
95% CI
Control Arm
4.8
0 – 10
Treatment Arm
2.4
0 – 10
Prescription for Opioid at DischargeSecondary· postoperative day 2 through postoperative day 7
Did the patient require a narcotic prescription
Group
Value
95% CI
Control Arm
4
Treatment Arm
1
Length of Hospital StaySecondary· postoperative day 1 through discharge or 4 weeks, whichever comes first
The average number of days patients were admitted as inpatient.
Group
Value
95% CI
Control Arm
2
2 – 2
Treatment Arm
2
2 – 2
Sponsor's own description
The objective of this study is to evaluate narcotic use after implementation of a Non-Opioid Multimodal Pain (NOMO) protocol in patients who are undergoing a urogynecologic procedure. The study will also evaluate secondary outcomes, including: post-operative pain rating, length of hospital stay, postoperative antiemetic use, bladder catheterization at discharge, number of post-operative phone calls, and rate of reported side effects of opioid use (nausea/constipation). Study participants will be asked to utilize the validated Brief Pain Inventory (appendix A) scale to assess post-operative pain levels. Based on inpatient post-operative opioid use and number of opioid pills prescribed at discharge, an attempt will be made to develop an algorithm for recommended opioid prescribing patterns.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07342504 — Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist
· NA
· recruiting
NCT07004686 — Effect of MGRNOX-Guided General Anesthesia on Opioid Consumption in Patients
· NA
· recruiting
NCT06981195 — Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects
· Phase 2
· recruiting
NCT06806163 — Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
· NA
· recruiting
NCT06909851 — Comparison of Pain Relief After Arthroscopic Knee Surgery: Adductor Canal Block and Genicular Nerve Block
· NA
· recruiting
Other Prisma Health-Upstate trials
Trials by the same sponsor.
NCT07202039 — Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine
· NA
· not yet recruiting
NCT07375212 — VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure
· Phase 4
· withdrawn
NCT06874413 — Targeted Prehabilitation With Physical Exercise and Inspiratory Muscle Training for Elderly Frail Patients Prior to Vent
· NA
· enrolling by invitation
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Prisma Health-Upstate
Last refreshed: 23 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05386069.